Cancer related gene alteration analysis study in patients with endometrial cancer
Not Applicable
- Conditions
- endometrial cancer
- Registration Number
- JPRN-UMIN000027294
- Lead Sponsor
- SRL Medisearch Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients judged by their physician to be unfit to participate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method [Blood] Gene mutation and chromosome copy number abnormality analysis using the Droplet Digital PCR. PIK3CA gene mutation, AKT1 gene mutation and amplification, AKT2 gene amplification. [FFPE tumor tissue] Analysis using Droplet Digital PCR and PCR. PIK3CA gene mutation, AKT1 gene mutation and amplification, AKT2 gene amplification.
- Secondary Outcome Measures
Name Time Method [FFPE tumor tissue] Gene analysis using NGS Target gene will be updated in the future depending on the contents of the chip.